Results 231 to 240 of about 13,261 (250)

Diagnosis of chronic inflammatory demyelinating polyneuropathy

Muscle & Nerve, 2022
AbstractChronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic immune‐mediated peripheral form of polyneuropathy. No reliable diagnostic biomarkers are available by which to make the diagnosis of CIDP. As a result, diagnosis of the condition can be challenging.
Jeffrey A. Allen, Richard A. Lewis
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy

Neuromuscular Disorders, 2006
Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired neuropathy, presumably of immunological origin. Its clinical presentation and course are extremely variable. CIDP is one of the few peripheral neuropathies amenable to treatment. Typical cases associate progressive or relapsing-remitting motor and sensory deficit with increased CSF
openaire   +3 more sources

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Current Neurology and Neuroscience Reports, 2015
Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the acquired demyelinating neuropathies and is considered to be immune mediated. Diagnosis is typically based on clinical history, neurologic examination, electrophysiologic studies, CSF studies, and pathologic examination.
Inna Kleyman, Inna Kleyman, Thomas H. Brannagan   +2 more
openaire   +3 more sources

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Current Treatment Options in Neurology, 2010
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated, non-length-dependent polyradiculoneuropathy that is progressive or relapsing over a period of at least 8 weeks, often evolving over time to a relatively symmetric pattern.
Peter D. Donofrio, Eliza E. Robertson
openaire   +3 more sources

Treatment of chronic inflammatory demyelinating polyneuropathy

Expert Review of Neurotherapeutics, 2003
Chronic inflammatory demyelinating polyradiculoneuropathy is a neuromuscular disorder for which immunological factors are undoubtedly important in the etiopathogenesis. As clinical recognition of this disorder has improved, immunosuppressive and immunomodulating treatments have emerged as the treatments of choice and the prognosis for patients with ...
Ryan L Kaplan, James W. Albers
openaire   +3 more sources

Dysautonomic polyneuropathy as a variant of chronic inflammatory “demyelinating” polyneuropathy? [PDF]

Clinical Autonomic Research, 2016
This report describes the clinical course over almost one decade of a male patient presenting with immune-mediated pure autonomic neuropathy resembling a distinct variant of chronic dysimmune polyneuropathies. We suppose autoantibodies directed against epitopes on autonomic axons or neurons causative for the symptoms.
Andreas Posa, Joachim Weis, Malte Kornhuber, Hans-Heinrich Wolf   +3 more
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy (CIDP)

Acta Neurologica Scandinavica, 2012
Chronic immune-mediated demyelinating polyneuropathies can often lead to severe neurologic disability.Literature review and personal experience with these types of neuropathies.It is important to recognize these immune-mediated neuropathies as they respond to treatment.
Elisabeth Farbu, Christian A. Vedeler, Svein Ivar Mellgren, Svein Ivar Mellgren   +3 more
openaire   +3 more sources

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV

Muscle & Nerve, 2009
AbstractPatients with chronic inflammatory demyelinating polyneuropathy (CIDP) received immune globulin intravenous, 10% caprylate/chromatography purified (IGIV‐C, Gamunex; n = 59) or placebo (n = 58) every 3 weeks for up to 24 weeks (first period) in a randomized, double‐blind, parallel‐group, response‐conditional, crossover study.
Bril, V, Katzberg, H, Donofrio, P, Banach, M, Dalakas, Mc, Deng, C, Hanna, K, Hartung, Hp, Hughes, Ra, Latov, N, Merkies, Is, van Doorn, Pa, Ice, Sg, Adamova, B, Apostolski, S, Artamonov, I, Banach, M, Barroso, F, Bartosik Psujek, H, Basta, I, Bednarik, J, Belniak, E, Benedetti, L, Bogucki, A, Bojar, M, Buchman, A, Caress, J, Chapman, J, Chapman, K, Cho, S, Chyrchel, U, Comi, G, Dacci, P, Del Carro, U, Divac, V, Drory, V, Dubrovsky, A, Ehler, E, Fazio, R, Fryze, W, Fulgenzi, E, Ghiglione, E, GRANDIS, MARINA, Gonzalez Cornejo, S, Gonzalez Jaime, J, Groozman, G, Haas, J, Kaminski, M, Kostera Pruszczyk, A, Kwiecinski, H, Lautre, A, Malaguti, M, Marchesoni, C, Munch, C, Narciso, E, Nations, S, Nogués, M, Oh, S, Pardal, A, Patwa, H, Pavlovic, S, Pozdzik Koseda, A, Reisin, R, Rivero, A, Romero Vargas, S, Ruiz Sandoval, J, SCHENONE, ANGELO, Selmaj, K, Stelmasiak, Z, Swaitkiewicz, J, Szadkowska, I, Szczudlik, A, Thomas, F, Trikic, R, Trivedi, J, Tsao, B, Uncini, A, Villa, A, Vohanka, S, Wolfe, G, Zielinska, M.   +80 more
openaire   +4 more sources

Chronic inflammatory demyelinating polyneuropathy.

International journal of tissue reactions, 1985
In 12 cases of CIDP under surveillance for 14 years, the main nerve biopsy findings were endoneural oedema and demyelination of nerve fibres. IgM deposition was found in 1 patient and IgG deposits in another. Electron microscopy revealed proliferation of the Schwann cells and mononuclear cell infiltration.
RIZZUTO, Nicolo', SIMONATI, Alessandro
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy in childhood

Pediatric Neurology, 2001
Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is relatively rare. However, it has been recognized for many years. In patients presenting with this disease, subacute onset of weakness usually develops over at least 2 months and often progresses to a loss of ambulation. Some children's initial presentations may mimic Guillain-Barré
openaire   +3 more sources